DAPK3 抗体 (AA 28-161)
Quick Overview for DAPK3 抗体 (AA 28-161) (ABIN5542452)
抗原
See all DAPK3 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
- 
    - 
                                            抗原表位
- AA 28-161
- 
                                            原理
- DAPK3 Antibody
- 
                                            纯化方法
- Purified antibody
- 
                                            免疫原
- Purified recombinant fragment of human DAPK3 (AA: 28-161) expressed in E. Coli.
- 
                                            亚型
- IgG1
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- 
                        ELISA: 1/10000 FCM: 1/200 - 1/400 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            缓冲液
- Purified antibody in PBS with 0.05 % sodium azide.
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- 4 °C,-20 °C
- 
                                            储存方法
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
 
- 
                                            
- 
    - DAPK3 (Death-Associated Protein Kinase 3 (DAPK3))
- 
                                            别名
- DAPK3
- 
                                            背景
- Death-associated protein kinase 3 (DAPK3) induces morphological changes in apoptosis when overexpressed in mammalian cells. These results suggest that DAPK3 may play a role in the induction of apoptosis.
- 
                                            分子量
- 52.5 kDa
- 
                                            基因ID
- 1613
- 
                                            UniProt
- O43293
 抗原
- 
                    
 
                                     
                                     
                                    